Trademark: 90712222
Word
BMD
Status Date
Monday, July 1, 2024
Filing Date
Friday, May 14, 2021
Published for Opposition
Tuesday, October 4, 2022
Abandoned Date
Monday, July 1, 2024
5 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GENETIC DISEASES THAT INVOLVE DYSREGULATION OF EPIGENETIC ENZYMES
42 PHARMACEUTICAL RESEARCH AND DEVELOPMENT
May 18, 2021
New Application Entered
Aug 13, 2021
New Application Office Supplied Data Entered
Jan 24, 2022
Assigned To Examiner
Jan 31, 2022
Non-Final Action Written
Jan 31, 2022
Non-Final Action E-Mailed
Jan 31, 2022
Notification Of Non-Final Action E-Mailed
Aug 1, 2022
Teas Response To Office Action Received
Aug 1, 2022
Correspondence Received In Law Office
Aug 2, 2022
Teas/Email Correspondence Entered
Aug 29, 2022
Approved For Pub - Principal Register
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Oct 4, 2022
Published For Opposition
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
May 19, 2023
Sou Teas Extension Received
May 19, 2023
Sou Extension 1 Filed
May 19, 2023
Sou Extension 1 Granted
May 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 22, 2023
Teas Change Of Owner Address Received
Jun 22, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 22, 2023
Teas Change Of Correspondence Received
Nov 9, 2023
Sou Teas Extension Received
Nov 9, 2023
Sou Extension 2 Filed
Nov 9, 2023
Sou Extension 2 Granted
Nov 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 1, 2024
Abandonment - No Use Statement Filed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
